Physician-Formulated: What It Actually Means (and Why It Should Matter to You)

By Kristina Braly, MD — Founder, AEMBR

I want to be careful about this one, because "physician-formulated" is a claim that can mean almost anything — and in some cases, it means very little.

There are products on the market that carry a physician's name on the label because that physician served as a paid consultant, reviewed the formula once, and moved on. There are products marketed as physician-designed where the physician's involvement was in brand positioning, not in the chemistry. I'm not interested in criticizing those arrangements, but I think it's worth being direct about what the phrase actually denotes versus what it implies — and what my specific background brought to AEMBR that I believe justifies using it.

What Medical Training Actually Teaches About Ingredients

Medical school doesn't teach formulation chemistry. That was a discipline I had to learn separately, and I did — working through the formulation science alongside the clinical toxicology I already had. But what medical training does provide, which is genuinely relevant to cleaning product development, is a specific framework for evaluating evidence about chemical exposures and health outcomes.

In clinical medicine, we spend years learning to distinguish between different qualities of evidence. A case report is not the same as a randomized controlled trial. An in vitro study showing that a compound damages cells at a very high concentration is not the same as evidence that the compound causes harm at the concentrations found in household products. A correlation between two variables in an epidemiological study is not the same as demonstrated causation.

This distinction matters enormously in the conversation about cleaning product safety — because the evidence landscape is genuinely mixed, and much of the popular discussion about "toxic" household products doesn't engage with it carefully.

Some ingredients with concerning names have very well-characterized safety profiles at the concentrations used in household products. Some ingredients with innocuous names have poorly studied long-term exposure profiles. "Synthetic" doesn't mean dangerous. "Natural" doesn't mean safe. "Plant-derived" is a feedstock description, not a toxicity assessment. These are things I knew from clinical medicine before I ever started formulating, and they shaped how I approached every ingredient decision.

What I Looked for Before I'd Use an Ingredient

When I was building AEMBR's formulas, my evaluation of every ingredient ran through several questions:

What does the peer-reviewed literature actually say? Not the brand's claims about an ingredient. Not activist organization concern profiles, which are sometimes precautionary beyond what the evidence supports. The primary literature — the studies, the systematic reviews, the exposure assessments published in peer-reviewed toxicology journals. I'm trained to read that literature critically. I used that training.

At what concentration? Toxicology has a foundational principle: the dose makes the poison. An ingredient with a concerning research profile at industrial concentrations may have a completely acceptable safety record at the trace concentrations used in consumer products — or it may not. The concentration question matters enormously, and many popular ingredient-concern discussions omit it entirely.

What is the exposure route and duration? Dermal exposure, inhalation, and ingestion have different absorption profiles. A compound that raises concerns at high inhalation levels may have minimal dermal absorption. Occupational exposures in industrial settings — the research context for many concerning ingredient studies — are qualitatively different from consumer use at home. I applied the same pharmacokinetic thinking I used in clinical practice.

For whom? Risk profiles differ by population. The safety evidence for a preservative in a healthy adult is different from the evidence relevant to a household with infants, pregnant women, or immunocompromised members. I formulated with the most sensitive household members as the reference population — not the median healthy adult.

Is there a safer alternative that performs equivalently? This is where formulation chemistry came in. Having evaluated the evidence on an ingredient, the next question was: if this ingredient presents any concern at meaningful exposure levels, does an alternative exist that doesn't — and does it work? Where the answer was yes, I used the alternative. Where the safety profile of the conventional ingredient was actually quite strong, I evaluated it on its merits rather than excluding it on reputation alone.

The Specific Decisions Medical Training Changed

Three formulation decisions where my clinical background directly shaped the outcome:

Preservative selection. Preservatives are necessary in aqueous formulas — without them, products become microbially unsafe. The question is which preservatives. I spent significant time in the toxicology literature on isothiazolinone derivatives (MIT, CMIT, BIT) — compounds widely used in cleaning products with documented skin sensitization potential, particularly in leave-on applications. The evidence on rinse-off concentrations in cleaning products is more mixed, but the sensitization mechanism is well-established. I excluded them from AEMBR formulas and use organic acid-based preservation systems instead, accepting the additional formulation complexity this requires.

Chelating agent choice. Hard water management in cleaning formulas typically relies on chelating agents — compounds that bind calcium and magnesium ions to prevent interference with cleaning performance. EDTA (ethylenediaminetetraacetic acid) is the conventional choice: effective, inexpensive, and poorly biodegradable. The environmental concern is well-characterized; it persists in water treatment and can mobilize heavy metals in aquatic environments. I use MGDA and GLDA — amino acid-derived chelating agents with equivalent performance and substantially better biodegradability. This was a cost and availability trade-off, but an easy decision given the comparative evidence.

Fragrance approach. The fragrance-as-trade-secret exemption is the most significant disclosure gap in this category. I've spent time in the clinical literature on fragrance sensitivity and sensitization — it's a real and underappreciated source of adverse reactions in the population. For cleaning products, which contact surfaces throughout the home and produce some level of inhalation exposure during use, I concluded that either full fragrance ingredient disclosure or fragrance-free was the only defensible position. We disclose fragrance components in AEMBR products that carry a scent, and we offer fragrance-free options across the line.

What Physician-Formulated Doesn't Mean

It doesn't mean the products are medical-grade or clinically validated in the way a pharmaceutical is. Cleaning product safety and efficacy claims are not subject to FDA pre-market approval. The rigorous clinical trial infrastructure that governs pharmaceutical development doesn't apply here.

It doesn't mean every ingredient concern that gets attention online is necessarily a legitimate concern. I apply the same evidence standard to activist ingredient worries that I apply to industry safety claims — I want the primary literature, not the summary. Sometimes that means concluding an ingredient flagged by popular concern databases is actually well-characterized and safe at use concentrations. Physician-formulated means I'm making that assessment rather than outsourcing it to marketing.

And it doesn't mean I get every decision right. Formulation science is a discipline I learned alongside my medical training, not in parallel with it. I've made formula iterations based on performance data and user feedback. I expect to continue to. The physician credential matters for the evidence-evaluation framework; it doesn't make me infallible as a formulator.

Why It Should Matter to You

The cleaning product market is full of claims — natural, non-toxic, plant-powered, clean — that are largely unregulated and mean whatever the brand says they mean. In that environment, a physician-formulated claim backed by actual clinical evidence evaluation means something different from the same claim backed by a marketing consultant's positioning brief.

The way to evaluate the difference is to ask what the brand discloses and how they defend it. Published ingredient lists with specific compound names, not categories. Explanations of formulation choices that engage with the evidence, not just the talking points. Willingness to say "this ingredient has a concerning profile in some contexts but is appropriate at this concentration for this application" — which is more useful than either reflexive inclusion or reflexive exclusion.

That's what I've tried to build with AEMBR. You can read my background and the story behind the brand, and you can evaluate the laundry powder's full ingredient list against everything I've described here. I'd rather you verify it than take it on faith.

Further Reading

• What Are Laundry Detergent Ingredients? A Complete Breakdown
• How to Read a Cleaning Product Label (and What They're Hiding)
• Are "Clean" Cleaning Products Actually Effective?

Kristina Braly, MD, is the physician founder of AEMBR. She holds a medical degree and writes about ingredient safety, clean formulation science, and evidence-based approaches to home health. Nothing in this article constitutes medical advice.